Would the once-a-week injector ‘Trulicity’ alter the once-a-day pattern?

While GLP-1 analogues have attracted interests of the industry due to obesity control as well as the hypoglycemic function, the injection-type GLP-1 analogue ‘Trulicity (generic name: dulaglutide),’ which can be injected once a week, has been launched.

Compared to the existing GLP-1 analogues requiring injection once a day, how convenience to inject once a week will change the trend attracted ...